<DOC>
	<DOCNO>NCT01294462</DOCNO>
	<brief_summary>The purpose study assess efficacy ( prevention vascular event ) safety ( especially bleeding ) Ticagrelor ( AZD6140 ) compare Clopidogrel , give top low dose aspirin , Asian/Japanese patient acute coronary syndrome plan percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Study Assess Safety Efficacy Ticagrelor ( AZD6140 ) Versus Clopidogrel Asian/Japanese Patients With Non-ST ST Elevation Acute Coronary Syndromes ( ACS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Provision sign informed consent Index event nonST ST segment elevation ACS Index event acute complication percutaneous coronary intervention Patient undergone Percutaneous Coronary Intervention ( PCI ) index event first dose study treatment Oral anticoagulation therapy stop The condition associate increase risk bradycardiac event</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>acute coronary syndrome</keyword>
	<keyword>coronary disease</keyword>
	<keyword>coronary artery disease</keyword>
</DOC>